Exploring how daclatasvir-based regimens are revolutionizing Hepatitis C treatment with cure rates exceeding 95% and their role in global elimination efforts.
Exploring the billion-year evolutionary arms race between viruses and their hosts, with insights into modern antiviral strategies and ancient viral conflicts.